The pattern and risk factors associated with adverse drug reactions induced by Reteplase in patients with acute ST-elevation myocardial infarction: The first report from Iranian population

Objective: Acute myocardial infarction (AMI) is one of the main leading causes of mortality and morbidity. Reteplase is a fibrin-specific thrombolytic which is used in the treatment of AMI. There is a limited number of studies reporting the postmarketing adverse drug reactions (ADRs) induced by rete...

Full description

Bibliographic Details

Published in:	Journal of Research in Pharmacy Practice
Main Authors:	Naser Aslanabadi, Naser Safaie, Faezeh Shadfar, Mohammad Reza Taban-Sadeghi, Hossein Feizpour, Simin Ozar Mashayekhi, Hadi Hamishehkar, Naser Khezerlou Aghdam, Samaneh Dousti, Hossein Namdar, Taher Entezari-Maleki
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2015-01-01
Subjects:	Acute myocardial infarction; adverse drug reactions; Reteplase
Online Access:	http://www.jrpp.net/article.asp?issn=2319-9644;year=2015;volume=4;issue=4;spage=206;epage=211;aulast=Aslanabadi